The largest database of trusted experimental protocols

2 protocols using solution 8

1

Mitochondrial Membrane Potential Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
The potential of the mitochondrial membrane was evaluated using the image cytometry technique, which allows demarcation of the percentage of cells with a polarized or depolarized mitochondrial membrane. The analysis is based on a fluorescent cationic dye JC-1 accumulating inside the mitochondria with a high transmembrane potential. At high concentrations, JC-1 aggregates and shows red fluorescence. In turn, JC-1 localizes in the cytoplasm in cells with a low mitochondrial potential and then shows green fluorescence. The tested melanoma cells were stained with JC-1 after the treatment by adding 12.5 µL of Solution 7 (200 µg/mL JC-1) (ChemoMetec, Lillerød, Denmark) to cell suspensions in PBS (1.0 × 106 cells/mL). Then, the samples were incubated for 30 min at 37 °C, centrifuged and washed twice with PBS. Immediately before the analysis, the cells were suspended with 0.25 mL of Solution 8 (1 µg/mL DAPI in PBS) (ChemoMetec, Lillerød, Denmark). The analysis was made according to the Mitochondrial Potential Assay protocol using NucleoCounter® NC-3000™.
+ Open protocol
+ Expand
2

Meloxicam Effects on Fibroblast and Melanocyte

Check if the same lab product or an alternative is used in the 5 most similar protocols
Meloxicam was obtained from Boehringer Ingelheim (Budapest, Hungary). Fibroblasts Growth Medium, amphotericin B solution (250 µg/mL), penicillin, phosphate-buffered saline (PBS) and L-3,4-dihydroxyphenylalanine (L-DOPA) were purchased from Sigma Aldrich Inc. (St. Louis, MO, USA). Neomycin sulfate was acquired from Amara (Kraków, Poland). An M-254 growth medium and a human melanocyte growth supplement-2 (HMGS-2) were obtained from Cascade Biologics (Portland, OR, USA). Trypsin/EDTA was obtained from Cytogen (Zgierz, Poland). Via-1-Cassettes™ (acridine orange and DAPI fluorophores), NC-slides A2 and A8, as well as Solution 3 (1 µg/mL DAPI, 0.1% triton X-100 in PBS), Solution 5 (VB-48™ PI AO), Solution 7 (200 µg/mL JC-1) and Solution 8 (1 µg/mL DAPI in PBS) were purchased from ChemoMetec (Lillerød, Denmark). H2DCFDA reagent was acquired from Thermo Fisher Scientific Inc. (Waltham, MA, USA). WST-1 cell proliferation reagent was obtained from Roche GmbH (Mannheim, Germany). Other chemicals were obtained from POCH S.A. (Gliwice, Poland).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!